Theralink Technologies Statistics
Theralink Technologies (THER) Stock Statistics & Valuation Metrics
Total Valuation
Theralink Technologies has a market cap or net worth of $6,151.00. The enterprise value is $19.38T.
- Market Cap
- $6,151.00
- Enterprise Value
- $19.38T
Share Statistics
Theralink Technologies has 6,151,500,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 6,151,500,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Theralink Technologies’s return on equity (ROE) is 0.81 and return on invested capital (ROIC) is 48.92%.
- Return on Equity (ROE)
- 0.81
- Return on Assets (ROA)
- -10.85
- Return on Invested Capital (ROIC)
- 48.92%
- Return on Capital Employed (ROCE)
- 0.24
- Revenue Per Employee
- 37.92K
- Profits Per Employee
- -1.93M
- Employee Count
- 16
- Asset Turnover
- 0.21
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Theralink Technologies is -0.00. Theralink Technologies’s PEG ratio is 0.00.
- PE Ratio
- -0.00
- PS Ratio
- 1.01
- PB Ratio
- -0.00
- Price to FCF
- -0.10
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Theralink Technologies had revenue of 606.80K and earned -30.91M in profits. Earnings per share was -0.50.
- Revenue
- 606.80K
- Gross Profit
- 480.56K
- Operating Income
- -8.98M
- Pretax Income
- -30.91M
- Net Income
- -30.91M
- EBITDA
- -8.73M
- Earnings Per Share (EPS)
- -0.50
Cash Flow
In the last 12 months, operating cash flow was -4.75M and capital expenditures -163,376, giving a free cash flow of -4.91M billion.
- Operating Cash Flow
- -4.75M
- Free Cash Flow
- -4.91M
- Free Cash Flow per Share
- -0.10
Dividends & Yields
Theralink Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -965.33%
- Earnings Yield
- -502438.52%
Stock Price Statistics
- Beta
- -15.85
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.02
- 200-Day Moving Average
- 0.02
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Theralink Technologies as a current ratio of 0.03, with Debt / Equity ratio of -51.85%
- Current Ratio
- 0.03
- Quick Ratio
- 0.03
- Debt to Market Cap
- 356.94
- Net Debt to EBITDA
- -2.15
- Interest Coverage Ratio
- -0.53
Taxes
In the past 12 months, Theralink Technologies has paid 16.71M in taxes.
- Income Tax
- 16.71M
- Effective Tax Rate
- -0.54
Enterprise Valuation
Theralink Technologies EV to EBITDA ratio is -2.22, with an EV/FCF ratio of -3.26.
- EV to Sales
- 31.94
- EV to EBITDA
- -2.22
- EV to Free Cash Flow
- -3.26
- EV to Operating Cash Flow
- -3.36
Balance Sheet
Theralink Technologies has $998.28K in cash and marketable securities with $19.76M in debt, giving a net cash position of -$18.76M billion.
- Cash & Marketable Securities
- $998.28K
- Total Debt
- $19.76M
- Net Cash
- -$18.76M
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- -$0.62
Margins
Gross margin is 79.20%, with operating margin of -1479.80%, and net profit margin of -5093.56%.
- Gross Margin
- 79.20%
- Operating Margin
- -1479.80%
- Pretax Margin
- -5093.56%
- Net Profit Margin
- -5093.56%
- EBITDA Margin
- -1439.10%
- EBIT Margin
- -1479.80%
Analyst Forecast
The average price target for Theralink Technologies is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
